-+ 0.00%
-+ 0.00%
-+ 0.00%

*CervoMed Expects EXPERTS-ALS to Dose First Patient With ALS With Neflamapimod by End of 2026 >CRVO

Dow Jones·05/18/2026 11:35:00

Please log in to view news